Clincosm LogoSign in Get a demo

Haemophilia A

Showing 51 - 73 of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Berlin, Germany
  • +4 more
Feb 9, 2017

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa pegol
  • Iowa City, Iowa
  • +17 more
Feb 9, 2017

Congenital Bleeding Disorder, Haemophilia A Trial in Japan (turoctocog alfa)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Itabashi-ku, Tokyo, Japan
  • +5 more
Feb 9, 2017

Haemophilia Care and Orthopaedic Status in Developing Countries

Completed
  • Congenital Bleeding Disorder
  • +4 more
  • No treatment given
  • Bangalore, India
  • +3 more
Jan 17, 2017

Pain on Functional Impairment and Quality of Life in Hemophilia

Completed
  • Congenital Bleeding Disorder
  • +4 more
  • No treatment given
  • Plainsboro, New Jersey
    Novo Nordisk Investigational Site
Jan 17, 2017

Congenital Bleeding Disorder, Haemophilia A, Haemophilia B Trial in Worldwide (activated recombinant human factor VII)

Completed
  • Congenital Bleeding Disorder
  • +2 more
  • activated recombinant human factor VII
  • Bremen, Germany
  • +7 more
Jan 11, 2017

NovoSeven® in Haemophilia and Inhibitors by Means of UK

Completed
  • Congenital Bleeding Disorder
  • +2 more
  • activated recombinant human factor VII
  • Crawley, United Kingdom
    Novo Nordisk Investigational Site
Nov 15, 2016

Congenital Bleeding Disorder, Haemophilia A, Haemophilia B Trial in Madrid (activated recombinant human factor VII, long acting)

Completed
  • Congenital Bleeding Disorder
  • +2 more
  • activated recombinant human factor VII, long acting
  • Madrid, Spain
    (unnamed)
May 12, 2016

Congenital Bleeding Disorder, Haemophilia A, Haemophilia B Trial in Harrow (activated recombinant human factor VII, long acting,

Completed
  • Congenital Bleeding Disorder
  • +3 more
  • activated recombinant human factor VII, long acting
  • placebo
  • Harrow, United Kingdom
    (unnamed)
May 12, 2016

Congenital Bleeding Disorder, Haemophilia A, Haemophilia B Trial in Berlin, Kitakyusyu,, Madrid (NNC 0128-0000-2011)

Completed
  • Congenital Bleeding Disorder
  • +2 more
  • NNC 0128-0000-2011
  • Berlin, Germany
  • +2 more
May 12, 2016

Congenital Bleeding Disorder, Haemophilia A, Haemophilia B Trial in Lille, München, Tel Hashomer (activated recombinant human

Completed
  • Congenital Bleeding Disorder
  • +2 more
  • activated recombinant human factor VII
  • Lille, France
  • +2 more
May 11, 2016

Current Treatment Practice in European Haemophilia Care

Completed
  • Haemophilia A
  • Haemophilia B
    • Brussel, Belgium
    • +11 more
    Mar 11, 2016

    Project to Update the Study of Congenital Haemophilia in Spain

    Completed
    • Congenital Bleeding Disorder
    • +2 more
    • No treatment given
    • Madrid, Spain
      (unnamed)
    Nov 27, 2015

    Haemophilic Case

    Completed
    • Haemophilia B
    • Haemophilia A
    • blood sampling
    • Saint-Etienne, France
      Chu Saint-Etienne
    Aug 12, 2015

    Tool to assIst in Follow up Care of haeMophilia A Patients

    Completed
    • Haemophilia A
    • Recombinant Factor VIII (Kogenate FS, BAY14-2222)
    • Many Locations, France
    • +1 more
    Aug 7, 2015

    To Quantify Range of Main Psychosocial Factors Affecting

    Completed
    • Congenital Bleeding Disorder
    • +5 more
    • No treatment given
    • Säo Paulo, Brazil
      (unnamed)
    Jul 9, 2015

    Room Temperature Stable NovoSeven® in Haemophilia A or B

    Completed
    • Congenital Bleeding Disorder
    • +2 more
    • activated recombinant human factor VII
    • Prov. de Buenos Aires, Argentina
    • +13 more
    Apr 15, 2015

    Congenital Bleeding Disorder, Haemophilia A, Haemophilia A With Inhibitors Trial in Madrid (eptacog alfa (activated))

    Completed
    • Congenital Bleeding Disorder
    • +4 more
    • eptacog alfa (activated)
    • Madrid, Spain
      (unnamed)
    Nov 13, 2014

    NovoSeven® in Home Treatment of Joint Bleeds in Haemophilia A or

    Completed
    • Congenital Bleeding Disorder
    • +2 more
    • activated recombinant human factor VII
    • Algiers, Algeria
    • +4 more
    Nov 13, 2014

    Congenital Bleeding Disorder, Haemophilia A, Haemophilia B Trial in Manchester (NNC 0128-0000-2011, NNC 0128-0000-2021)

    Completed
    • Congenital Bleeding Disorder
    • +2 more
    • NNC 0128-0000-2011
    • NNC 0128-0000-2021
    • Manchester, United Kingdom
      (unnamed)
    Aug 19, 2014

    Haemophilia A, Haemophilia B Trial in Brussels (custom-molded insoles and custom-molded shoes)

    Completed
    • Haemophilia A
    • Haemophilia B
    • custom-molded insoles and custom-molded shoes
    • Brussels, Belgium
      cliniques Universitaires Saint Luc
    Jul 10, 2014

    Congenital Bleeding Disorder, Haemophilia A, Haemophilia A With Inhibitors Trial (activated recombinant human factor VII,

    Withdrawn
    • Congenital Bleeding Disorder
    • +5 more
    • activated recombinant human factor VII
    • eptacog alfa (activated)
    • (no location specified)
    Mar 24, 2014

    Haemophilia A Trial in Moscow, St. Petersburg (Kogenate FS, reconstituted in a suspension of liposomes)

    Completed
    • Haemophilia A
    • Kogenate FS, reconstituted in a suspension of liposomes
    • Moscow, Russian Federation
    • +2 more
    Oct 15, 2007